id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2010-N-0002-0088,FDA,FDA-2010-N-0002,New Animal Drugs: Deslorelin,Rule,NFR-Notice of Final Rule,2010-12-28T05:00:00Z,2010,12,2010-12-28T05:00:00Z,,2010-12-28T15:43:43Z,2010-32554,0,0,0900006480bc0c09
FDA-2010-N-0002-0087,FDA,FDA-2010-N-0002,New Animal Drugs; Change of Sponsor's Address,Rule,NFR-Notice of Final Rule,2010-12-21T05:00:00Z,2010,12,2010-12-21T05:00:00Z,,2010-12-21T14:31:22Z,2010-31952,0,0,0900006480bbcc1e
FDA-2010-N-0002-0085,FDA,FDA-2010-N-0002,New Animal Drugs: Mupirocin,Rule,NFR-Notice of Final Rule,2010-12-20T05:00:00Z,2010,12,2010-12-20T05:00:00Z,,2010-12-20T14:51:05Z,2010-31870,0,0,0900006480bba052
FDA-2000-N-0011-0006,FDA,FDA-2000-N-0011,Uniform Compliance Date for Food Labeling Regulations,Rule,NFR-Notice of Final Rule,2010-12-15T05:00:00Z,2010,12,2010-12-15T05:00:00Z,2011-02-15T04:59:59Z,2010-12-16T16:05:14Z,2010-31382,0,0,0900006480bb6fad
FDA-2010-N-0002-0081,FDA,FDA-2010-N-0002,Oral Dosage Form New Animal Drugs: Tylosin,Rule,NFR-Notice of Final Rule,2010-12-08T05:00:00Z,2010,12,2010-12-08T05:00:00Z,,2010-12-08T15:43:21Z,2010-30814,0,0,0900006480bb1e23
FDA-2010-N-0002-0083,FDA,FDA-2010-N-0002,Implantation or Injectable Dosage Form New Animal Drugs: Flunixin,Rule,NFR-Notice of Final Rule,2010-12-08T05:00:00Z,2010,12,2010-12-08T05:00:00Z,,2010-12-08T16:18:02Z,2010-30769,0,0,0900006480bb1ea7
FDA-2010-N-0560-0002,FDA,FDA-2010-N-0560,Amendments to General Regulations of Food and Drug Administration,Rule,NFR-Notice of Final Rule,2010-11-30T05:00:00Z,2010,11,2010-11-30T05:00:00Z,2011-02-15T04:59:59Z,2011-06-11T16:28:39Z,2010-30039,0,0,0900006480ba9048
FDA-2010-N-0002-0080,FDA,FDA-2010-N-0002,New Animal Drugs: Change of Sponsor's Name and Address,Rule,NFR-Notice of Final Rule,2010-11-26T05:00:00Z,2010,11,2010-11-26T05:00:00Z,,2024-11-07T22:30:37Z,2010-29693,1,0,0900006480ba43cf
FDA-2010-N-0002-0079,FDA,FDA-2010-N-0002,Intramammary Dosage Form New Animal Drugs: Cloxacillin Benzathine,Rule,NFR-Notice of Final Rule,2010-11-22T05:00:00Z,2010,11,2010-11-22T05:00:00Z,,2024-11-07T22:25:26Z,2010-29326,1,0,0900006480ba0922
FDA-2010-N-0513-0001,FDA,FDA-2010-N-0513,Medical Devices; General and Plastic Surgery Devices: Classification of Non-Powered Suction Apparatus Device Intended for NegativePressure Wound Therapy,Rule,NFR-Notice of Final Rule,2010-11-17T05:00:00Z,2010,11,,,2010-11-17T21:39:49Z,2010-28873,0,0,0900006480b954fb
FDA-2010-N-0534-0002,FDA,FDA-2010-N-0534,New Animal Drugs for Minor Use and Minor Species,Rule,NFR-Notice of Final Rule,2010-11-15T05:00:00Z,2010,11,2010-11-15T05:00:00Z,2011-02-01T04:59:59Z,2024-11-12T04:55:47Z,2010-28550,1,0,0900006480b88cdc
FDA-2010-N-0002-0078,FDA,FDA-2010-N-0002,New Animal Drugs; Change of Sponsor: Sulfadiazine and Pyrimethamine Suspension,Rule,NFR-Notice of Final Rule,2010-11-15T05:00:00Z,2010,11,,,2010-11-15T17:45:37Z,2010-28549,0,0,0900006480b88cdb
FDA-2010-N-0002-0077,FDA,FDA-2010-N-0002,New Animal Drugs; Change of Sponsors Name,Rule,CEP-Certificate Extending Patent Term,2010-11-10T05:00:00Z,2010,11,2010-11-10T05:00:00Z,,2010-11-10T15:57:56Z,2010-28307,0,0,0900006480b86258
FDA-2010-N-0512-0001,FDA,FDA-2010-N-0512,Medical Devices; General and Plastic Surgery Devices: Classification of Tissue Adhesive With Adjunct Wound Closure Device Intended for Topical Approximation of Skin,Rule,CEP-Certificate Extending Patent Term,2010-11-10T05:00:00Z,2010,11,2010-11-10T05:00:00Z,,2012-09-27T02:01:12Z,2010-28356,0,0,0900006480b861ad
FDA-2008-N-0273-0018,FDA,FDA-2008-N-0273,Medical Devices: Radiology Devices; Reclassification of Full-Field Digital Mammography System,Rule,NFR-Notice of Final Rule,2010-11-05T04:00:00Z,2010,11,,,2010-11-05T17:36:15Z,2010-28007,0,0,0900006480b8254d
FDA-2010-N-0002-0075,FDA,FDA-2010-N-0002,Oral Dosage Form New Animal Drugs: Domperidone,Rule,NFR-Notice of Final Rule,2010-11-01T04:00:00Z,2010,11,,,2010-11-01T15:15:29Z,2010-27524,0,0,0900006480b7c883
FDA-2010-N-0002-0074,FDA,FDA-2010-N-0002,New Animal Drugs: Change of Sponsor; Monensin Blocks,Rule,NFR-Notice of Final Rule,2010-10-28T04:00:00Z,2010,10,,,2010-10-28T15:36:14Z,2010-27287,0,0,0900006480b79676
FDA-2010-N-0002-0073,FDA,FDA-2010-N-0002,"Animal Drugs, Feeds, and Related Products; Withdrawals of Approvals of New Animal Drug Applications: Aklomide; Levamisole Hydrochloride; Nitromide and Sulfanitran",Rule,NFR-Notice of Final Rule,2010-10-26T04:00:00Z,2010,10,,,2010-10-26T14:48:15Z,2010-27011,0,0,0900006480b7753a
FDA-2010-N-0002-0071,FDA,FDA-2010-N-0002,Certain Other Dosage Form New Animal Drugs: Progesterone Intravaginal Inserts,Rule,NFR-Notice of Final Rule,2010-10-14T04:00:00Z,2010,10,,,2010-10-14T17:22:27Z,2010-25893,0,0,0900006480b6eed0
FDA-1981-N-0299-0007,FDA,FDA-1981-N-0299,Order to Revise Existing Standards and Establishment of New Identity Standards; Final Rule,Rule,NFR-Notice of Final Rule,2010-10-12T04:00:00Z,2010,10,2010-10-12T04:00:00Z,1973-11-10T04:59:59Z,2010-10-12T22:36:48Z,,0,0,09000064805b14b7
FDA-2010-N-0002-0069,FDA,FDA-2010-N-0002,Implantation and Injectable Dosage Form New Animal Drugs: Ceftiofur Crystalline Free Acid; Technical Amendment,Rule,NFR-Notice of Final Rule,2010-10-12T04:00:00Z,2010,10,2010-10-12T04:00:00Z,,2010-10-12T15:25:22Z,2010-25527,0,0,0900006480b6c491
FDA-1982-F-0155-0002,FDA,FDA-1982-F-0155,Direct Food Additives: Food Additives Permitted For Direct Addition To Food For Human Consumption; Dimethyl Dicarbonate,Rule,NFR-Notice of Final Rule,2010-10-07T04:00:00Z,2010,10,2010-10-07T04:00:00Z,1988-11-22T04:59:59Z,2010-10-07T15:25:08Z,,0,0,090000648050f626
FDA-2010-N-0002-0066,FDA,FDA-2010-N-0002,Implantation or Injectable Dosage Form New Animal Drugs; Dexmedetomidine,Rule,NFR-Notice of Final Rule,2010-09-30T04:00:00Z,2010,9,2010-09-30T04:00:00Z,,2010-09-30T15:28:17Z,2010-24494,0,0,0900006480b64109
FDA-2010-N-0002-0068,FDA,FDA-2010-N-0002,New Animal Drugs for Use in Animal Feeds; Melengestrol,Rule,NFR-Notice of Final Rule,2010-09-30T04:00:00Z,2010,9,2010-09-30T04:00:00Z,,2010-09-30T15:42:59Z,2010-24480,0,0,0900006480b64158
FDA-2000-N-0108-0071,FDA,FDA-2000-N-0108,Final Rule re Investigational New Drug Safety Reporting Requirements for Human Drug and Biological Products: Safety Reporting Requirements for Bioavailability and Bioequivalence Studies in Humans,Rule,Final Rule,2010-09-29T04:00:00Z,2010,9,2010-09-29T04:00:00Z,,2016-02-24T19:19:31Z,2010-24296,0,0,0900006480b63055
FDA-2010-N-0002-0064,FDA,FDA-2010-N-0002,Implantation and Injectable Dosage Form New Animal Drugs: Firocoxib,Rule,NFR-Notice of Final Rule,2010-09-28T04:00:00Z,2010,9,2010-09-28T04:00:00Z,,2010-09-28T14:58:35Z,2010-24254,0,0,0900006480b62263
FDA-2009-N-0344-0003,FDA,FDA-2009-N-0344,Microbiology Devices: Reclassification of Herpes Simplex Virus Types 1 and 2 Serological Assays; Confirmation of Effective Date,Rule,NCD-Notice of Confirmation of Effective Date,2010-09-28T04:00:00Z,2010,9,2010-09-28T04:00:00Z,,2010-09-28T14:23:52Z,2010-23638,0,0,0900006480b62224
FDA-2010-N-0002-0063,FDA,FDA-2010-N-0002,"Animal Drugs, Feeds, and Related Products; Withdrawals of Approvals of New Animal Drug Applications: Chloramphenicol; Lincomycin;Pyrantel Tartrate; and Tylosin Phosphate and Sulfamethazine",Rule,NFR-Notice of Final Rule,2010-09-14T04:00:00Z,2010,9,,,2010-09-14T15:22:40Z,2010-22808,0,0,0900006480b4ea9e
FDA-1997-N-0011-0047,FDA,FDA-1997-N-0011,"Notice of Final Rule re Human Cells, Tissues, and Cellular and Tissue-Based Products; Establishment Registration and Listing",Rule,Final Rule,2010-09-10T04:00:00Z,2010,9,2010-09-10T04:00:00Z,,2016-01-14T18:25:10Z,,0,0,09000064805c9af7
FDA-2000-P-0924-0002,FDA,FDA-2000-P-0924,Final Rule- Cardiovascular Devices: Reclassification of Certain Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheters,Rule,NFR-Notice of Final Rule,2010-09-08T04:00:00Z,2010,9,2010-09-08T04:00:00Z,,2024-08-08T16:30:24Z,2010-22304,0,0,0900006480b48181
FDA-2010-N-0002-0062,FDA,FDA-2010-N-0002,Ophthalmic and Topical Dosage Form New Animal Drugs: Gentamicin and Betamethasone Ophthalmic Solution; Technical Amendment,Rule,NFR-Notice of Final Rule,2010-09-08T04:00:00Z,2010,9,2010-09-08T04:00:00Z,,2010-09-09T15:50:59Z,2010-22276,0,0,0900006480b48200
FDA-2010-N-0002-0061,FDA,FDA-2010-N-0002,Oral Dosage Form New Animal Drugs: Tiamulin,Rule,NFR-Notice of Final Rule,2010-09-08T04:00:00Z,2010,9,2010-09-08T04:00:00Z,,2010-09-09T16:00:35Z,2010-22277,0,0,0900006480b481aa
FDA-2010-N-0002-0056,FDA,FDA-2010-N-0002,New Animal Drugs: Change of Sponsor's Name and Address,Rule,NFR-Notice of Final Rule,2010-09-03T04:00:00Z,2010,9,2010-09-03T04:00:00Z,,2010-09-03T14:51:56Z,2010-22044,0,0,0900006480b4490f
FDA-2010-N-0002-0057,FDA,FDA-2010-N-0002,New Animal Drugs; Change of Sponsor: Penicillin G Benzathine and Penicillin G Procaine Suspension; Penicillin G Procaine Aqueous Suspension,Rule,NFR-Notice of Final Rule,2010-09-03T04:00:00Z,2010,9,2010-09-03T04:00:00Z,,2010-09-03T15:04:07Z,2010-22042,0,0,0900006480b449d2
FDA-2010-N-0002-0052,FDA,FDA-2010-N-0002,New Animal Drugs for Use in Animal Feed: Ractopamine,Rule,NFR-Notice of Final Rule,2010-09-03T04:00:00Z,2010,9,2010-09-03T04:00:00Z,,2010-09-03T14:36:56Z,2010-22071,0,0,0900006480b444d4
FDA-2010-N-0002-0054,FDA,FDA-2010-N-0002,Implantation or Injectable Dosage Form New Animal Drugs: Florfenicol and Flunixin,Rule,NFR-Notice of Final Rule,2010-09-03T04:00:00Z,2010,9,,,2010-09-03T14:45:33Z,2010-22039,0,0,0900006480b444ef
FDA-2010-N-0002-0058,FDA,FDA-2010-N-0002,Oral Dosage Form New Animal Drugs: Praziquantel and Pyrantel,Rule,NFR-Notice of Final Rule,2010-09-03T04:00:00Z,2010,9,2010-09-03T04:00:00Z,,2010-09-03T15:07:38Z,2010-22043,0,0,0900006480b449d4
FDA-2010-N-0002-0051,FDA,FDA-2010-N-0002,New Animal Drugs; Changes of Sponsors; Withdrawals of Approvals of New Animal Drug Applications: Deslorelin Acetate; Dichlorophene and Toluene Capsules; Pyrantel Pamoate Suspension,Rule,CEP-Certificate Extending Patent Term,2010-08-27T04:00:00Z,2010,8,2010-08-27T04:00:00Z,,2010-08-27T13:34:20Z,2010-21296,0,0,0900006480b3c459
FDA-1993-N-0150-0002,FDA,FDA-1993-N-0150,Financial Disclosure by Clinical Investigators; Correction,Rule,NCR-Notice of Correction,2010-07-27T04:00:00Z,2010,7,2010-07-27T04:00:00Z,,2010-07-27T20:52:38Z,,0,0,09000064804ff2da
FDA-2009-N-0458-0010,FDA,FDA-2009-N-0458,"Medical Devices; Pediatric Uses of Devices; Requirements for Submission of Information, etc.: Withdrawal",Rule,NWL-Notice of Withdrawl,2010-07-20T04:00:00Z,2010,7,,,2011-06-11T16:28:04Z,2010-17617,0,0,0900006480b1cf7d
FDA-1990-F-0131-0002,FDA,FDA-1990-F-0131,Food Additives Permitted in Feed and Drinking Water of Animals; Formaldehyde; Final Rule,Rule,NFR-Notice of Final Rule,2010-07-06T04:00:00Z,2010,7,2010-07-06T04:00:00Z,1996-05-10T03:59:59Z,2010-09-21T01:16:03Z,,0,0,090000648052cfa0
FDA-2010-N-0002-0048,FDA,FDA-2010-N-0002,Implantations or Injectable Dosages Form New Animal Drugs: Propofol,Rule,NFR-Notice of Final Rule,2010-07-06T04:00:00Z,2010,7,,,2010-07-06T15:44:47Z,2010-16301,0,0,0900006480b13970
FDA-2010-N-0010-0005,FDA,FDA-2010-N-0010,Change of Address; Abbreviated New Drug Applications; Technical Amendment,Rule,NFR-Notice of Final Rule,2010-06-29T04:00:00Z,2010,6,,,2010-06-29T13:41:29Z,2010-15711,0,0,0900006480b0c81f
FDA-2008-C-0098-0006,FDA,FDA-2008-C-0098,Listing of Color Additives Exempt from Certification: Bismuth Citrate; Confirmation of Effective Date,Rule,NCD-Notice of Confirmation of Effective Date,2010-06-17T04:00:00Z,2010,6,,,2010-10-29T01:09:59Z,2010-14598,0,0,0900006480b03b70
FDA-2010-N-0002-0045,FDA,FDA-2010-N-0002,New Animal Drugs for Use in Animal Feeds: Florfenicol,Rule,NFR-Notice of Final Rule,2010-06-17T04:00:00Z,2010,6,,,2010-10-29T01:10:45Z,2010-14611,0,0,0900006480b03b6f
FDA-2008-N-0163-0294,FDA,FDA-2008-N-0163,"Dental Devices: Classification of Dental Amalgam, Reclassification of Dental Mercury, Designation of Special Controls for Dental Amalgam, Mercury, and Amalgam Alloy; Technical Amendment",Rule,NFR-Notice of Final Rule,2010-06-11T04:00:00Z,2010,6,,,2011-06-11T16:27:42Z,2010-14083,0,0,0900006480b002a6
FDA-2010-N-0010-0004,FDA,FDA-2010-N-0010,Change of Contact Information; Technical Amendment,Rule,N-Notice,2010-06-09T04:00:00Z,2010,6,2010-06-09T04:00:00Z,,2010-06-09T16:29:08Z,2010-13820,0,0,0900006480afeb5e
FDA-2010-N-0002-0041,FDA,FDA-2010-N-0002,Ophthalmic and Topical Dosage Form New Animal Drugs: Ivermectin Topical Solution,Rule,NFR-Notice of Final Rule,2010-05-12T04:00:00Z,2010,5,2010-05-12T04:00:00Z,,2010-05-12T13:53:44Z,2010-11244,0,0,0900006480aebea3
FDA-2010-N-0002-0039,FDA,FDA-2010-N-0002,Implantation or Injectable Dosage Form New Animal Drugs: Ivermectin,Rule,NFR-Notice of Final Rule,2010-05-12T04:00:00Z,2010,5,2010-05-12T04:00:00Z,,2010-05-12T13:37:48Z,2010-11282,0,0,0900006480aebe42
FDA-2010-N-0002-0043,FDA,FDA-2010-N-0002,Oral Dosages Form New Animal Drugs: Orbifloxacin Suspension,Rule,NFR-Notice of Final Rule,2010-05-12T04:00:00Z,2010,5,2010-05-12T04:00:00Z,,2010-05-12T14:14:28Z,2010-11245,0,0,0900006480aebeee
FDA-2010-N-0002-0038,FDA,FDA-2010-N-0002,"Animal Drugs, Feeds, and Related Products: Withdrawal of Approval of a New Animal Drug Application; Buquinolate; Coumaphos",Rule,NFR-Notice of Final Rule,2010-05-05T04:00:00Z,2010,5,2010-05-05T04:00:00Z,,2010-05-05T18:21:18Z,2010-10564,0,0,0900006480ae7219
FDA-1992-N-0132-0001,FDA,FDA-1992-N-0132,Food and Color Additives; Generally Recognized As Safe Substances; Technical Amendments,Rule,Final Rule,2010-04-30T04:00:00Z,2010,4,2010-04-30T04:00:00Z,,2023-09-20T12:50:19Z,92-7106,0,0,090000648052dbd3
FDA-1986-F-0378-0002,FDA,FDA-1986-F-0378,"Irradiation In The Production, Processing, and Handling of Foods",Rule,Final Rule,2010-04-30T04:00:00Z,2010,4,2010-04-30T04:00:00Z,1989-03-24T04:59:59Z,2023-02-10T17:02:33Z,89-3864,0,0,09000064805110a0
FDA-2010-N-0002-0035,FDA,FDA-2010-N-0002,Implantation or Injectable Dosage Form New Animal Drugs: Butorphanol,Rule,NFR-Notice of Final Rule,2010-04-29T04:00:00Z,2010,4,,,2010-04-29T14:05:53Z,2010-09871,0,0,0900006480ae39a6
FDA-2010-N-0002-0032,FDA,FDA-2010-N-0002,Certain Other Dosage Form New Animal Drugs; Detomidine,Rule,NFR-Notice of Final Rule,2010-04-23T04:00:00Z,2010,4,,,2010-04-23T15:05:24Z,2010-09371,0,0,0900006480ade6c3
FDA-2010-N-0010-0003,FDA,FDA-2010-N-0010,Center for Devices and Radiological Health; New Address Information,Rule,NFR-Notice of Final Rule,2010-04-22T04:00:00Z,2010,4,,,2010-04-22T14:01:49Z,2010-08863,0,0,0900006480adcfd6
FDA-2010-N-0002-0030,FDA,FDA-2010-N-0002,"New Animal Drugs for Use in Animal Feeds: Melengestrol, Monensin, and Ractopamine",Rule,NFR-Notice of Final Rule,2010-04-22T04:00:00Z,2010,4,,,2010-04-22T13:40:34Z,2010-09304,0,0,0900006480adcfba
FDA-2010-N-0002-0028,FDA,FDA-2010-N-0002,New Animal Drugs: Change of Sponsor,Rule,NFR-Notice of Final Rule,2010-04-20T04:00:00Z,2010,4,2010-04-20T04:00:00Z,,2024-11-12T04:53:46Z,2010-09057,1,0,0900006480adba4f
FDA-2010-N-0002-0029,FDA,FDA-2010-N-0002,New Animal Drugs: Change of Sponsor,Rule,NFR-Notice of Final Rule,2010-04-20T04:00:00Z,2010,4,2010-04-20T04:00:00Z,,2024-11-12T04:53:58Z,2010-09045,1,0,0900006480adbad7
FDA-2010-N-0002-0027,FDA,FDA-2010-N-0002,Implantation or Injectable Dosage Form New Animal Drugs: Change of Sponsor; Propofol,Rule,NFR-Notice of Final Rule,2010-04-19T04:00:00Z,2010,4,2010-04-19T04:00:00Z,,2024-11-07T22:17:54Z,2010-08945,1,0,0900006480adaf52
FDA-2006-N-0304-0039,FDA,FDA-2006-N-0304,"Use of Ozone-Depleting Substances; Removal of Essential-Use Designation: Flunisolide, etc.",Rule,NFR-Notice of Final Rule,2010-04-14T04:00:00Z,2010,4,2010-04-14T04:00:00Z,,2011-06-11T16:25:59Z,2010-08467,0,0,0900006480ad7218
FDA-2000-N-0190-0110,FDA,FDA-2000-N-0190,"Prevention of Salmonella Enteritidis in Shell Eggs During Production, Storage, and Transportation, etc.; Technical Amendment",Rule,NFR-Notice of Final Rule,2010-04-13T04:00:00Z,2010,4,,,2010-04-13T14:28:09Z,2010-08358,0,0,0900006480ad65c5
FDA-1975-N-0017-0050,FDA,FDA-1975-N-0017,See FDA-1975-N-0017-0028,Rule,NFR-Notice of Final Rule,2010-04-09T04:00:00Z,2010,4,2010-04-09T04:00:00Z,,2011-02-08T14:46:37Z,,0,0,0900006480ad3b5e
FDA-1999-N-3539-0001,FDA,FDA-1999-N-3539,Technical Amendments: Administrative Practices and Procedures; Good Guidance Practices,Rule,Final Rule,2010-04-01T04:00:00Z,2010,4,,,2015-11-10T15:50:14Z,2010-07286,0,0,0900006480ace273
FDA-2009-N-0458-0002,FDA,FDA-2009-N-0458,"Medical Devices; Pediatric Uses of Devices: Requirement for Submission of Information on Pediatric Subpopulations That Suffer From a Disease, et al.",Rule,NFR-Notice of Final Rule,2010-04-01T04:00:00Z,2010,4,2010-04-01T04:00:00Z,2010-06-16T03:59:59Z,2011-06-11T16:28:04Z,2010-07193,0,0,0900006480ace1bb
FDA-2010-N-0010-0002,FDA,FDA-2010-N-0010,Technical Amendments: Medical Devices,Rule,NFR-Notice of Final Rule,2010-04-01T04:00:00Z,2010,4,,,2010-04-01T15:59:32Z,2010-07288,0,0,0900006480ace17c
FDA-2010-N-0002-0025,FDA,FDA-2010-N-0002,"Ophthalmic and Topical Dosage Form New Animal Drugs: Orbifloxacin, Mometasone Furoate Monohydrate, and Posaconazole Suspension",Rule,NFR-Notice of Final Rule,2010-04-01T04:00:00Z,2010,4,,,2010-04-01T16:05:18Z,2010-07163,0,0,0900006480ace19b
FDA-2010-N-0148-0001,FDA,FDA-2010-N-0148,Revision of Organization and Conforming Changes to Regulations,Rule,NFR-Notice of Final Rule,2010-04-01T04:00:00Z,2010,4,,,2010-04-01T15:54:52Z,2010-07282,0,0,0900006480ace164
FDA-2003-N-0446-0027,FDA,FDA-2003-N-0446,New Animal Drugs: Removal of Obsolete and Redundant Regulations,Rule,NFR-Notice of Final Rule,2010-03-31T04:00:00Z,2010,3,2010-03-31T04:00:00Z,,2010-03-31T18:16:34Z,2010-07108,0,0,0900006480acd296
FDA-2003-N-0446-0026,FDA,FDA-2003-N-0446,New Animal Drugs for Use in Animal Feeds; CFR Correction,Rule,CFR-Correction,2010-03-30T04:00:00Z,2010,3,2010-03-30T04:00:00Z,,2010-03-31T18:32:57Z,2010-07095,0,0,0900006480acc25e
FDA-2010-N-0001-0032,FDA,FDA-2010-N-0001,Advisory Committees; Technical Amendment,Rule,NFR-Notice of Final Rule,2010-03-29T04:00:00Z,2010,3,,,2010-03-29T14:47:46Z,2010-06861,0,0,0900006480aca86c
FDA-2008-C-0098-0003,FDA,FDA-2008-C-0098,Listing of Color Additives Exempt From Certification: Bismuth Citrate,Rule,NFR-Notice of Final Rule,2010-03-26T04:00:00Z,2010,3,2010-04-26T04:00:00Z,,2010-04-22T16:10:20Z,2010-06731,0,0,0900006480ac9372
FDA-1993-N-0259-0016,FDA,FDA-1993-N-0259,Beverages; Bottled Water,Rule,Final Rule,2010-03-24T04:00:00Z,2010,3,2010-03-24T04:00:00Z,,2024-04-12T12:24:50Z,96-6940,0,0,0900006480503ebc
FDA-2010-N-0010-0001,FDA,FDA-2010-N-0010,Product Jurisdiction: Change of Address and Telephone Number; Technical Amendment,Rule,NFR-Notice of Final Rule,2010-03-23T04:00:00Z,2010,3,2010-03-23T04:00:00Z,,2010-03-23T15:23:04Z,2010-06246,0,0,0900006480ac615b
FDA-2010-N-0002-0023,FDA,FDA-2010-N-0002,Implantation or Injectable Dosage Form New Animal Drugs: Flunixin,Rule,NFR-Notice of Final Rule,2010-03-19T04:00:00Z,2010,3,,,2010-03-19T14:36:48Z,2010-06038,0,0,0900006480ac18f4
FDA-1995-N-0259-0002,FDA,FDA-1995-N-0259,Regulations Restricting the Sale and Distribution of Cigarettes and Smokeless Tobacco To Protect Children and Adolescents,Rule,NFR-Notice of Final Rule,2010-03-19T04:00:00Z,2010,3,,,2011-06-11T16:25:43Z,2010-06087,0,0,0900006480ac184d
FDA-2010-N-0002-0022,FDA,FDA-2010-N-0002,Oral Dosage Form New Animal Drugs: Tetracycline Powder; Technical Amendment,Rule,NFR-Notice of Final Rule,2010-03-18T04:00:00Z,2010,3,2010-03-18T04:00:00Z,,2010-03-18T15:23:20Z,2010-05925,0,0,0900006480ac0362
FDA-2010-N-0002-0016,FDA,FDA-2010-N-0002,New Animal Drugs for Use in Animal Feeds: Zilpaterol,Rule,NFR-Notice of Final Rule,2010-03-11T05:00:00Z,2010,3,,,2010-03-11T15:33:43Z,2010-05224,0,0,0900006480abaf98
FDA-2009-N-0436-0003,FDA,FDA-2009-N-0436,Confirmation of Effective Date: New Animal Drug Applications,Rule,NCD-Notice of Confirmation of Effective Date,2010-03-08T05:00:00Z,2010,3,2010-03-08T05:00:00Z,,2010-03-08T20:12:22Z,2010-04923,0,0,0900006480ab81f2
FDA-2010-N-0002-0014,FDA,FDA-2010-N-0002,New Animal Drugs: Change of Sponsor,Rule,NFR-Notice of Final Rule,2010-03-05T05:00:00Z,2010,3,,,2010-03-09T14:28:56Z,2010-04560,0,0,0900006480ab5f5b
FDA-1992-N-0049-0028,FDA,FDA-1992-N-0049,Classification of Benzoyl Peroxide as Safe and Effective and Revision of Labeling to Drug Facts Format; Topical Acne Drug Products for Over-the-Counter Human Use; Final Rule,Rule,NFR-Notice of Final Rule,2010-03-04T05:00:00Z,2010,3,2010-03-04T05:00:00Z,,2010-03-08T06:09:32Z,,0,0,0900006480ab4f84
FDA-1981-N-0114-0001,FDA,FDA-1981-N-0114,Classification of Benzoyl Peroxide as Safe and Effective and Revision of Labeling to Drug Facts Format; Topical Acne Drug Products for Over-the-Counter Human Use; Final Rule,Rule,NFR-Notice of Final Rule,2010-03-04T05:00:00Z,2010,3,,,2011-06-11T16:25:43Z,2010-04424,0,0,0900006480ab4db0
FDA-2010-N-0002-0009,FDA,FDA-2010-N-0002,New Animal Drugs for Use in Animal Feeds: Bacitracin Zinc; Nicarbazin,Rule,NFR-Notice of Final Rule,2010-02-22T05:00:00Z,2010,2,2010-02-22T05:00:00Z,,2010-02-23T13:57:08Z,2010-03328,0,0,0900006480aa9b3b
FDA-2009-N-0665-0085,FDA,FDA-2009-N-0665,New Animal Drugs; Change of Sponsor - Final Rule,Rule,Final Rule,2010-01-20T05:00:00Z,2010,1,2010-01-20T05:00:00Z,,2014-01-07T21:41:55Z,2010-00930,0,0,0900006480a802fb
FDA-2009-N-0665-0083,FDA,FDA-2009-N-0665,Implantation or Injectable Dosage Form New Animal Drugs; Florfenicol and Flunixin,Rule,Final Rule,2010-01-11T05:00:00Z,2010,1,,,2014-07-11T16:33:22Z,2010-00209,0,0,0900006480a7b385
FDA-2009-N-0665-0080,FDA,FDA-2009-N-0665,Implantation or Injectable Dosage Form New Animal Drugs; Hyaluronate Sodium - Final Rule,Rule,Final Rule,2010-01-11T05:00:00Z,2010,1,,,2014-01-07T21:41:03Z,2010-00207,0,0,0900006480a7b29f
FDA-2009-N-0665-0081,FDA,FDA-2009-N-0665,New Animal Drugs; Ractopamine - Final Rule,Rule,Final Rule,2010-01-11T05:00:00Z,2010,1,,,2014-01-07T21:43:54Z,2010-00208,0,0,0900006480a7b2e7